F. Amicet al., Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine, Baishideng Publishing Group Inc., Dec. 2018. doi: 10.3748/wjg.v24.i47.5366
My protocol during this period: Retatrutide: 2mg weekly subcutaneous injection (ramped to 4mg by week 10) GHK-Cu: 1mg daily subcutaneous, rotated injection sites Cycle length: 12 weeks on, 4 weeks off Training: 4 days resistance training per week, 8,000 to 10,000 steps daily Protein intake: 130g daily minimum I sourced both from Red Fox Peptides
From results to relationships, we focus on creating positive, lasting impressions
Takeuchi et al., 2008)
FDA Prescribing Information Mounjaro (Tirzepatide) injection Prescribing Information
Curiously, the strongest anxiolytic effect came from the smallest administered dose of 0.5 mcg/kg body weight, whereas larger doses had smaller effects on anxiety [12]